Protein phosphatase-1 (PP1) drives a large amount of phosphoSer/Thr protein dephosphorylations in eukaryotes to counteract multiple kinases in signaling pathways. The phosphatase requires divalent metal cations for catalytic activity and contains iron naturally. Iron has been suggested to have an influence on PP1 activity through Fe 2+ and Fe 3+ oxidation states. However, much biochemical and all structural data have been obtained with recombinant PP1 containing Mn 2+ ions. Purifying iron-containing PP1 from Escherichia coli has thus far not been possible. Here, we present the preparation, characterization, and structure of iron-bound PP1a in inactive and active states. We establish a key role for the electronic/redox properties of iron in PP1 activity and shed light on the difference in substrate specificity between iron-and manganese-containing PP1.
Protein phosphatase-1 (PP1) plays key roles in signaling pathways and its deregulation is implicated in severe diseases such as cancer and diabetes [1] . In particular, attempting to target PP1 in proteostasis diseases [2, 3] has motivated in recent years numerous studies on PP1 function and on the action mechanisms of drugs targeting PP1 [4] [5] [6] . For its catalytic activity, PP1 relies on two metal ions bound in its active site. A recent study described a new redox-regulatory mechanism for PP1 involving the metal ions [7] . The authors demonstrated that the enzyme NADPH oxidase-4 (Nox4) binds the PP1-targeting subunit GADD34, generates reactive oxygen species, and locally inhibits PP1. The applied recombinant PP1 contained largely Mn 2+ ions at both metal coordination sites of PP1's active site, and in the crystal structure the nature of the metal ions was unclear. Nevertheless, evidence by EPR measurements suggested that oxidation of Fe 2+ to Fe 3+ could be involved in the inactivation of PP1 [7] .
The catalytic subunit of native PP1 contains iron and zinc, and the presence of Mg 2+ cannot be ruled out, whereas Mn 2+ content is almost negligible [8] . Similar to the data on PP1 oxidation [7] , all structural and most biochemical data so far have been obtained using recombinant PP1 containing manganese ions (Mn-PP1) in the active site [8] . This is due to difficulties in purifying and producing a stable preparation of iron-bound PP1 (Fe-PP1), especially in amounts required for crystallography, which has prevented its use in studies so far [9] . Nevertheless, recombinant Mn-PP1a displayed some important differences from native PP1, isolated from rabbit skeletal muscle, such as altered substrate specificity, which are thus not reflected in in vitro studies using recombinant Mn-PP1 [8] . An earlier study suggested that conversion of native PP1 (PP1 N ) to a Mn 2+ -dependent state alters multiple structural elements in PP1 catalytic subunit, but so far this hypothesis could not be addressed in structural studies [10] . Thus, lack of biochemical and structural data on active PP1 bound to physiological metals currently hampers understanding its dephosphorylation chemistry and regulation. Addressing this need, we present here a protocol to obtain stable FePP1a, which we applied to obtain insights into the redox regulation of PP1 activity. We show that only the oxidation state of iron, not a conformational change, determines if PP1 is inactive or active.
Materials and methods

Protein expression and purification
The full-length gene (residues 1-330) coding for the a-isoform of the catalytic subunit of human protein phosphatase 1 (PP1a) was subcloned into pTXB1 expression vector fused at the C terminus with the intein tag. The gene was also fused with a cleavable N-terminal histidine tag. This construct was expressed in BL21Star(DE3)pRARE Escherichia coli strain, in Luria-Bertani broth supplemented with FeSO 4 (for Fe-PP1a, 0.1 g/1 L broth: 0.65 mM) or MnCl 2 (for Mn-PP1a, 1 mM [11, 12] ). FeSO 4 was chosen because it was found frequently reported in protocols for expression and purification in E. coli of ironcontaining recombinant proteins. The expression was conducted at 16°C overnight after induction with 50 lM isopropyl b-D-thiogalactoside. The cell paste collected by centrifugation was subjected to different passages through an Emulsiflex homogenizer in lysis buffer [25 mM TRIS-Cl, pH 7.5 at room temperature (RT), 300 mM NaCl, 10% v/v glycerol, 30 mM imidazole, 0.2% v/v tween-20, 0.1 mM phenylmethylsulfonyl fluoride, EDTA-free protease inhibitor cocktail from Roche Diagnostics GmbH, Mannheim, Germany, and benzonase from Merck, Darmstadt, Germany]. The soluble fraction obtained by centrifugation was spiked with NaCl to reach a concentration of 700 mM final, and loaded on a 5-mL HisTrap HP nickel column equilibrated in 25 mM TRIS-HCl, pH 7.5 RT, 700 mM NaCl, 5% v/v glycerol, 30 mM imidazole, 0.2% v/v tween-20. After an extensive wash with this buffer, and a stringent wash at 15% buffer B, the fused precursor was eluted with 100% buffer B (buffer A with 250 mM imidazole). The elution sample was extensively diluted to a final volume of 300 mL in buffer 25 mM TRIS-HCl, pH 7.5 at RT, 200 mM NaCl, 10% v/v glycerol, 0.1% v/v tween-20, and incubated overnight at 4°C with 50 mM b-mercaptoethanol (b-ME) and 1 mg of TEV protease to cleave both tags. This dilution step is critical for the cleavage efficiency and for solubility of PP1a. After incubation with chitin resin from New England Biolabs (NEB, Frankfurt am Main, Germany) to remove the cleaved intein tag, the protein sample was diluted to decrease NaCl concentration to 100 mM and loaded on a 5-mL Heparin HP column equilibrated in buffer Hep-A (20 mM TRIS-Cl, pH 7.5 RT, 100 mM NaCl, 5 mM b-ME) and subjected to an extensive wash step. PP1a was further purified with a gradient from 0% to 40% buffer Hep-B (buffer Hep-A with 1 M NaCl) in 30 min. The purest fractions were combined based on SDS/ PAGE and dialyzed against the storage buffer (50 mM TRIS-Cl, pH 7.5 RT, 200 mM NaCl, 10% v/v glycerol, 5 mM b-ME). In case of Mn-PP1a, 1 mM MnCl 2 was also added throughout purification and in the storage buffer [11, 12] .
Metal content was determined by inductively coupled plasma optical emission spectrometry (ICP-OES) with an Agilent ICP-OES 720 at the Institut f€ ur Geowissenschaften Universit€ at Heidelberg. The purified protein was passed through a PD10 column extensively washed and equilibrated with metal-clean buffer prepared by incubation with Chelex resin. The metal-clean buffer used for the buffer exchange was analyzed by ICP-OES for background subtraction.
Enzymatic assays
The native PP1 N (mixture of PP1a, b, c isoforms) was a kind gift of M. Bollen from the Department of Cellular and Molecular Medicine in Leuven, Belgium. The protein was purified from rabbit muscle and analyzed by mass spectrometry and western blot, which showed contamination with tropomyosin [6] . In most cases, we therefore used the enzyme in an approximate 10-fold higher concentration than the recombinant pure ones (see below). The storage buffer contained 60% glycerol, 50 mM TRIS-Cl pH 7.5 and 1 mM DTT.
In vitro activity assays were performed in 96 well plates with a Tecan Infinite M1000 PRO (Tecan-Deutschland GmbH, Crailsheim, Germany). All assays were conducted at 25°C in a final volume of 100 lL with three independent experiments. Each experiment including Fe-PP1a was designed in duplicate or triplicate, and Mn-PP1a was analyzed in parallel in the same plate. The activity buffer was 20 mM TRIS-Cl, pH 7.0 RT, 100 mM NaCl, 5 mM b-ME. No metals were included in the assay buffer, and 0.05% v/ v tween-20 was present only with DiFMUP (6,8- enzyme concentration of 100 nM in order to ensure possible detection of weak activity. Immediately prior to the activity assays, Fe-PP1a was reactivated by adding 5 mM sodium ascorbate and 1 mM FeCl 2 (chosen due to high usage of chloride salts compared to other salts in activity assays) for 15' in the dark at RT and in parallel Mn-PP1a was incubated similarly, with 1 mM fresh MnCl 2 and with or without 5 mM sodium ascorbate, both enzymes in 10 nM stock solution leading to a final concentration of ascorbate of 250 lM in the assays. Stock solutions of FeCl 2 and ascorbate were prepared fresh immediately prior to the reactivation. To minimize carryover of the excess metal from the enzyme solutions into the phosphatase assay, only 5 lL of the enzyme solution was added to the reaction mixture (final volume 100 lL for 96-well plate, corresponding to a residual final concentration of 0.05 mM for the metals). Control samples with buffer but no enzyme with or without 5 mM sodium ascorbate and 1 mM FeCl 2 or 1 mM MnCl 2 were incubated also at RT in the dark for 15', and were used for background wells with substrate, in order to rule out possible nonenzymatic reactions. The metal concentrations for the controls were chosen based on the fact that 1 mM FeCl 2 or MnCl 2 was added to the enzyme for incubation prior to the activity assay.
Activity assays with DiFMUP were conducted by monitoring the fluorescence of the product 6,8-difluoro-4-methylumbelliferone. The substrate DiFMUP was diluted in activity buffer so that the final concentration of DMSO was kept fixed at only 1.6%. The enzymatic activity was linear in respect to time and enzyme concentration. The final concentration of enzyme used was 0.5 nM for MnPP1a and Fe-PP1a and the substrate ranged from 12.5 to 400 lM. DiFMUP concentrations higher than 600 lM were not considered as substrate inhibition was observed. Native PP1 N was used at the concentration of 5 nM (approximate, includes tropomyosin [6] ). The activity assays with the H3pT3 peptide (sequence: AR-pT-KQTARKS) as substrate were performed with the EnzCheck Phosphate Assay (Themofischer, Scientific, Dreieich, Germany). In this assay, the production of phosphate by PP1 is coupled with the reaction of purine nucleoside phosphorylase (PNP, 0.15 unit) with 200 lM methylthioguanosine (MESG) as substrate. The final product 2-amino-6-mercapto-7-methylpurine is detected by monitoring the absorbance at 360 nm. The enzymatic activity was linear with respect to time and enzyme concentration, and it was assessed that the amount of coupled enzyme was not limiting. Addition of the peptide substrate did not alter the pH of the activity buffer. The substrate concentration ranged from 12.5 to 100 lM. The final concentration of enzyme used was 20 nM in all cases except for native PP1 N , which was used at 200 nM (approximate, includes tropomyosin [6] ). The activity assays with p-nitrophenylphosphat (pNPP) were carried out by measurement of the absorbance of the reaction product at 405 nm. The buffer used for the assay contained 50 mM TRIS-Cl, pH 7.5 RT, 200 mM NaCl, 0.1 mM EDTA, 2 mM DTT, and 0.1 mgÁmL
À1
BSA. The substrate range was from 40 to 1.25 mM. The final concentration of Mn-PP1a and Fe-PP1a was 50 nM. Because the amount of the native PP1 N was limited and previous studies [6, 13] showed already that it has very low to no activity toward pNPP, 50 nM (approximate, contains tropomyosin [6] ) of the enzyme was used for the assay (not the 10-fold excess compared to the recombinant pure proteins as for the other previously untested substrates). The kinetic parameters derived from these data were obtained with the GRAPHPAD PRISM 6 software (La Jolla, CA, USA). The kinetic data from Mn-PP1a were fitted to the Michaelis-Menten equation for DiFMUP and pNPP substrates, allowing the determination of the K m and k cat values. The kinetic data from Mn-PP1a with pNPP and H3pT3 peptide substrate, and from Fe-PP1a (for DiFMUP, pNPP, and H3pT3 substrates) displayed lack of saturation. In these cases, the data were fitted to a linear plot, where the resulting slope corresponded to the ratio V/K, which was further converted to k cat /K m after normalization with the product titration and with the concentration of the enzyme. A further comparison using only the two lower substrate concentrations (linear range for Mn-PP1a) and applying a linear fitting was done for Mn-PP1a and Fe-PP1a with the DiFMUP and H3pT3 peptide substrates. In this way we confirmed that the comparison between the differently calculated data qualitatively holds true when the parameters were calculated in the same way (data not shown).
To test the effect of Inhibitor-2 on Fe-and Mn-PP1a, an inhibition assay using DiFMUP as a phosphomimetic substrate was carried out. To this end, Inhibitor-2 was titrated five times 1 : 2 starting from 2 nM final concentration. Assay buffer composition was 20 mM Tris-Cl, 100 mM NaCl, 5 mM b-ME, 0.05% Tween, pH 7.0 substituted with 50 lM MnCl 2 or FeCl 2 for Mn-PP1a and Fe-PP1a, respectively, and AE250 lM ascorbate as indicated. Final protein concentrations in our assay setup were 0.5 nM for Mn-and Fe-PP1a with 100 lM DiFMUP. Assay measurement was carried out in a black 96-well plate at 25°C. Relative Fluorescent Units were detected at 450 nm using a Synergy H1 microplate reader (Bio-Tek Instruments GmbH, Bad Friedrichshall, Germany).
Structure determination
Fe-PP1a was subjected to gel filtration prior to crystallization. Activity tests in gel filtration buffer of Fe-PP1a not incubated with ascorbate confirmed that the protein was in the inactive state. Fe-PP1a was loaded on a Superdex 200 equilibrated in 50 mM TRIS-Cl, pH 7.5 RT, 500 mM NaCl, 5 mM b-ME and concentrated to 5 mgÁmL À1 . Crystals were grown by the vapor diffusion method in sitting To obtain the structure of reduced Fe-PP1a, one crystal of Fe-PP1a was soaked in 18 mM ascorbate for 15 min in the drop/reservoir solution, and flash cooled in liquid nitrogen adding 25% v/v glycerol to the precipitant solution as cryoprotectant. Data collection was carried out at beamline ID30A-3 at the European Synchrotron Radiation Facility (ESRF). Data processing was carried out with XDS [14] and AIMLESS [15] in the CCP4 suite [16] . The structure was solved by molecular replacement using PHA-SER [17] in the CCP4 suite [16] and the crystal structure of apo Mn-PP1a as search model (PDB code 4MOV) [18] . The structure was refined by alternating manual adjustment and model building in COOT [19] and restrained positional and B-factor refinement with REFMAC5 [20] . Structure figures were created in PYMOL (http://www.py mol.org) and CCP4MG [21] . Table 1 presents the data processing and refinement statistics. Fe-PP1a crystallized as monomer and similar to the other Mn-PP1 structures available, the first seven amino acids and the C-terminal tail are not visible. In this case, also the residues 20-24 do not have clear electron density and were therefore not modeled.
Accession codes
Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes PDB 6G0J (Fe(III)-PP1a) and PDB 6G0I (Fe(II)-PP1a).
Results and Discussion
We report here that expressing PP1a C-terminally fused to intein from the pTXB1 vector in MnCl 2 -supplemented broth gives higher yields than other protocols, suggesting a stable expression of the construct. This finding led us to hypothesize that this strategy would enable the incorporation of iron into the active site of PP1 during expression using FeSO 4 -supplemented broth. Indeed, this strategy allowed us to develop an efficient protocol for recombinant expression and purification of PP1a with stoichiometric iron. We obtained 17 mg of highly pure protein from 4 L of E. coli culture (Fig. S1A ), which represents a good yield suitable for biochemical and structural studies of iron-containing PP1. Metal content analysis by inductively coupled plasma optical emission spectrometry (ICP-OES) on two different preparations of the enzyme assessed that the ratio of iron concentration versus PP1a concentration (=1) was 0.85 AE 0.04 (two measurements, the error is the standard deviation SD). We did not detect any significant amount of zinc, rather PP1 contained manganese (0.36 AE 0.004) and magnesium (0.29 AE 0.006). The successful incorporation of iron could be explained by a C-terminal stabilization through the intein fusion. The C-terminal tail of PP1a is not visible in all the structures deposited in the PDB database and often a truncated version PP1a300 instead of PP1a330 is used to achieve crystallization. It is therefore possible that the fusion at the C terminus of the protein with a tag of 27 kDa helps the folding of PP1a by stabilization of the C-terminal region. The induction was carried out at low temperature and with very low concentration of inducer with the aim of slowing down protein synthesis to improve cofactor incorporation and protein folding. An important difference with previous protocols is the absence of addition of MnCl 2 to the growth medium and to the purification buffers, which usually most likely shifts the metal incorporation to the manganese form. Iron ions, as well as manganese ions, are already present in the normal growth media to a certain extent. However, additional FeSO 4 was added to the growth medium in order to favor the incorporation of iron over manganese. Subsequently, we attempted the incorporation of zinc together with iron to mimic the situation in the native enzyme. We added zinc (a) together with iron during expression, which was unsuccessful; (b) after the Ni 2+ -column purification of Fe-PP1a during cleavage of the tags, which led to incorporation of only about 10% as measured by ICP-OES, and (c) in a metal exchange of the purified Fe-PP1a protein, which led to unspecific binding of Zn 2+ to the protein as monitored after buffer exchange by ICP-OES. These attempts suggest that the incorporation of Zn 2+ during recombinant protein expression in E. coli is more challenging than that of iron and manganese. This is contrary to the situation in mammalian cells, where purification of native PP1 from animal tissue resulted instead in a high incorporation of zinc of 74% (1.48 lM zinc for a protein concentration of 2 lM) with no detectable manganese, and only 8% iron (0.16 lM iron for a protein concentration of 2 lM), which was interpreted as loss of iron during purification and/or storage [8] . When PP1 is expressed in E. coli, incorporation of zinc at a later stage during purification could be more difficult as the enzyme is already folded and the residual divalent cations already bound to the enzyme possibly disturb further zinc incorporation. Also, differences in cation availability and tolerance in bacteria and mammalian cells [22] could be a reason for the different preferential incorporation of metals into PP1.
Here, we then focused on the question of what effect the incorporation of iron has on structure and activity of PP1a compared to the presence of Mn 2+ . We tested the enzymatic activity of our Fe-PP1a sample with the fluorogenic substrate DiFMUP [11] , with para-nitrophenol phosphate (pNPP) [6, 13] , and with a phosphopeptide carrying the N-terminal sequence of histone 3, a known PP1 substrate (H3pT3 peptide) [12] . We did not detect dephosphorylation activity with an enzyme concentration as high as 100 nM with H3pT3 peptide (Fig. S1B) , and 1 nM with DiFMUP. As Fe-PP1a was purified in the presence of b-ME, a reducing agent that reduces cysteine residues but not iron (III), the freshly purified enzyme was likely in the oxidized Fe(III) state. In turn, incubation of the sample with 1 mM FeCl 2 and 5 mM ascorbate (Asc) for 15 min at RT [23] rescued enzymatic activity, and induced Fe(II)-PP1a-catalyzed H3pT3 peptide and DiFMUP dephosphorylation efficiently (Fig. 1A,C ; S1C,D) . However, with pNPP still no activity was observed (Fig. 1B) , which could reflect that the Fecontaining enzyme appears to be selective toward pSer as reported for the native PP1 N [6, 13] . Asc addition did not make a difference to the activity of Mn-PP1a (Fig. 1A,B,D) . Only at high DiFMUP concentration (400 lM) Asc-treated Mn-PP1a was somewhat more active than the untreated (Fig. S1C) , which could be due to residual Fe being present in Mn-PP1a [7] . These results support that oxidation of the iron renders the enzyme inactive and is consistent with the findings of Santos et al. [7] that ascorbate reactivates the metal center of PP1c during oxidative stress. We then compared the catalytic efficiency of reactivated Fe(II)-PP1a with that of Mn-PP1a using DiFMUP, pNPP and the more physiological H3pT3 peptide substrate ( Fig. 1D ; Table 2 ). Probably due to electrochemical properties resulting in a different nucleophilicity of Fe 2+ compared to Mn
2+
, Fe(II)-PP1a shows in general a lower activity than Mn-PP1a. However, the native enzyme showed a higher activity than Mn-PP1a [8] , and one explanation could be that this results from the combination of iron and zinc in the active site of native PP1 exerting an increase in the nucleophilicity of a water molecule and/or electrophilicity of the phosphate moiety in the substrate, or effecting the orientation of the substrate in the cavity [24] . We also found that the relative V/K m was higher with the H3pT3 peptide as a substrate for Fe(II)-PP1a, which together with the inactivity toward pNPP could reflect differences in substrate specificity compared to Mn-PP1a, as observed previously with purified native PP1 N [8] . We furthermore asked whether Fe(II)-PP1a and Mn-PP1a were both sensitive to Inhibitor2 (I2) inhibition, as the native PP1 N was found to be highly sensitive to this inhibition [25] , and also Mn-PP1a was previously shown to be sensitive to I2 [12] . We observed that both, Fe(II)-PP1a and Mn-PP1a, were sensitive to I2 inhibition ( Fig. 1E; Fig. S1D-F) . Addition of Asc did not change the degree of sensitivity of Mn-PP1a. Finally, we wondered how native PP1 N would behave toward the here tested substrates. Since the PP1 N used here contained a contamination (see the materials and methods), a quantitative comparison was not possible, and a titration with I2 was not feasible. Nevertheless, we observed that PP1 N dephosphorylated both DiFMUP and the H3pT3 peptide, whereas in agreement with previous studies [6, 13] , pNPP was not recognized (Fig. 2) . Under these conditions, the addition of Asc did not change the activity of the enzyme.
To investigate the structural effects of iron incorporation, we determined the 2.1 A crystal structure of Fe (III)-PP1a purified in the inactive state (see Table 1 for crystallization statistics). We also soaked crystals in 18 mM ascorbate to solve the structure of Fe(II)-PP1a in the active state. Inactive Fe(III)-PP1a forms an a/b fold highly similar to previous Mn-PP1 structures [18, [26] [27] [28] (Fig. 3A: rmsd 0.350 on superposition of Ca atoms [29] with PDB 4MOV), showing that inactivity of oxidized Fe(III)-PP1a is not due to major structural changes. The side chains overlay well with the structure of apo Mn-PP1a [18] (Fig. 3B) , without significant displacements of the active site residues, which gives validity to using Mn 2+ ions instead of iron in structural studies. As in Mn-PP1a, the two metal ions are bridged by the carboxylic group of D92 and position the catalytic water for the nucleophilic attack (see Fig. 3D for the electron density). The metal ion at site 1 is coordinated by the side chains of N124, H173, and H248, while the second metal binding site is formed by D64 and H66. Fe(III)-PP1 binds inorganic phosphate in the active site that mimics the substrate phosphate as in apo Mn-PP1a, with the side chain of R96 coordinating the phosphate group. Near the entrance to the active site, Y134 in Fe(III)-PP1a shows a different orientation than in Mn-PP1a, with a 1.3 A displacement of the hydroxyl group. The overlay with other Mn-PP1 structures confirms that although the hydroxyl group of Y134 is similarly pointed outwards in these, it is displaced in Fe-PP1a by 1.0-1.4 A [12, 30, 31] . The different orientation of Y134 is stabilized by one bridging water between Y134 and R96, which is not present in Mn-PP1, and this closer orientation toward the active site might account for differences in substrate accommodation. This finding is in agreement with the previous suggestion that incorporation of Mn 2+ might generate a more open active site [8] . Nevertheless, the presence of zinc in native PP1 could also contribute to substrate specificity, which due to the unaccomplished challenge of generating Fe-Zn-PP1 could not be addressed here. The structure of active Fe(II)-PP1a treated with ascorbate is essentially identical to Fe (III)-PP1a (rmsd 0.127 for superposition of Ca atoms [29] ) and closer inspection does not identify significant differences in the arrangement of the active site (Fig. 3C ). This result shows that the inhibition and rescue of phosphatase activity in Fe-PP1a do not rely on structural changes and are only related to the electronic properties of the iron cofactor.
In conclusion, we developed a protocol for expression and purification of PP1a, which provides good yields of highly pure and stable iron-containing enzyme. The protocol does not require expensive or time-consuming procedures such as the use of insect cell lines. The purified enzyme can be easily reactivated and used for biochemical studies. The incorporation of zinc together with iron will have to be accomplished in the future to answer questions on the role of zinc in the catalytic activity of PP1. Incorporation of iron into recombinant PP1 cannot account for all differences between PP1 N and bacterially expressed PP1a. For example, Fe(II)-PP1a is less active than Mn-PP1a, which in turn is less active than native PP1 [8] . Other factors, for example zinc as second metal, will account for that. Nevertheless, Fe(II)-PP1a behaves similar to PP1 N in terms of substrate preference, thus reflecting a characteristic of PP1 N . Furthermore, Fe-PP1a requires activation by oxidation, whereas native PP1 N does not, which could be due to the different expression environments including the presence/absence of cofactors and chaperones [13] to protect the iron in PP1 N against oxidation. While reversible oxidation of a catalytic cysteine is a well-established mechanism for regulation of protein tyrosine phosphatases [7] , the physiological regulation of PP1 by reversible metal oxidation is only beginning to unveil. Our findings show that the oxidation state of the iron, not structural rearrangements within PP1 or of another metal, decides on the activity of PP1, offering a fast redox switch to control PP1 activity. As the most common reducing agent for 1-electron reductions in the cell, the role of ascorbate in reverting oxidative inhibition of the iron cofactor in PP1a is physiologically highly relevant. Our studies have wide implications given that other members of the phosphoprotein phosphatase family also depend on metal ions for their catalytic mechanism and are redox regulated [32] [33] [34] . Furthermore, the recombinant inactive enzyme could potentially be used as a tool to trap PP1 substrates, altogether providing a resource for future studies of this important enzyme. . Similar to the extra density in apo Mn-PP1a, this is consistent with the presence of a phosphate group was observed near the metal ions. In the structure of Fe-PP1a cysteine side chains appear reduced, consistent with the use of b-ME in the purification and activity assays. Only the peripheral residues C127 and C273 present electron density consistent with oxidation to a sulfenic group. The same peripheral residues were oxidized in the crystal structure of Mn-PP1c and it was demonstrated that this oxidation did not affect enzymatic activity [7] . 
